What Grupo Cimed does

Grupo Cimed is a privately held Brazilian pharmaceutical company founded in 1976 and headquartered in São Paulo, operating as the third-largest pharmaceutical firm in Brazil by sales volume with a portfolio of over 600 products spanning generic medicines, over-the-counter drugs (e.g., Cimegripe, Nevralgex), vitamins and nutrition (Lavitan), personal care and beauty (Carmed, Acnezil, K-Med, Dermafeme, Xô Inseto, João e Maria), dermocosmetics (Bepantriz), and emerging entries into GLP-1 semaglutida. Manufacturing is anchored at a modern Pouso Alegre (Minas Gerais) complex with a newly inaugurated 2023 facility, supplemented by additional production in Santa Rita do Sapucaí and Chapecó and a centralized distribution hub in São Sebastião da Bela Vista.

The company's business model is a high-volume, pharmacy-anchored consumer health play. It distributes directly to over 60,000 pharmacy points of sale covering approximately 90% of Brazilian pharmacies through 24 distribution centers and state-level offices in every Brazilian state, with supplementary e-commerce via its own lavitan5g.com.br storefront. Revenue is generated through one-time unit sales across diverse price points, from low-cost generic promotions such as 'pague um leve dois' campaigns to mid-priced branded SKUs such as the Carmed Barbie collection at R$29.90 average retail. Brand-building is executed through an unusually aggressive marketing mix spanning official CBF national football team sponsorship, club deals with Cruzeiro and Palmeiras, influencer ambassadorships (Anitta for Puzzy, Nattan for Ressaliv, Mahmoud Baydoun for K-Med), and viral licensed collaborations (Barbie/Mattel, Fini, Burger King, Larissa Manoela), which together produced 22% revenue growth in 2022 (R$1.9B), record R$3B revenue in 2023, and an R$5 billion 2025 revenue target endorsed by newly appointed board member João Branco.

Name

Grupo Cimed

Legal name

CIMED & CO. S.A.

Website

https://cimedremedios.com.br

Company type

Private

Founded year

1976

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Grupo Cimed is a privately held Brazilian pharmaceutical company manufacturing over 600 generic, OTC, vitamin, personal care, and dermocosmetic products, distributed through 60,000+ pharmacy points covering 90% of Brazil's pharmacy retail network.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing / Consumer Healthcare

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (4242)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Multivitamins & Daily Packs (CRADAGAC)

Keywords

• Generic pharmaceutical manufacturing
• OTC consumer healthcare
• Vitamin and nutrition supplements
• Personal care products
• Dermocosmetic products

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices8 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D, Infrastructure

Revenue model

1. Generic Medicines: Sales of generic pharmaceutical products including prescription generics and OTC medications through pharmacy retail distribution network.
2. OTC and Consumer Health Products: Sales of over-the-counter medications, vitamins and nutrition supplements, personal care and beauty products, and dermocosmetics through pharmacies and direct-to-consumer channels.
3. Seasonal Illness Treatments: Sales of cold and flu medications, with seasonal peaks driving significant revenue (R$1 billion expected for winter seasonal illness treatments).

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Grupo Cimed manufactures and distributes a portfolio of over 600 pharmaceutical and consumer health products, including generic medicines, OTC medications (cold/flu, pain relief), vitamins and nutrition supplements, personal care and beauty products (lip balm, acne treatment, intimate care, baby care, insect repellent, intimate perfume), and dermocosmetics. Products are sold primarily through Brazil's pharmacy retail network (60,000+ points covering 90% of pharmacies), supplemented by direct-to-consumer e-commerce (lavitan5g.com.br) for vitamin and supplement lines.

Product overview

Cimed is a Brazilian pharmaceutical company offering a diversified portfolio of over 600 products across four main categories: Medicines (including OTC drugs, generics, cold/flu remedies like Cimegripe, pain relief like Nevralgex, and upcoming GLP-1 weight loss medications), Personal Care and Beauty (acne treatment line Acnezil, intimate care products Dermafeme and K-MED, lip balm brand Carmed, baby care João e Maria, insect repellent Xô Inseto!, and intimate perfume Puzzy by Anitta), Vitamins and Nutrition (vitamin supplements including Lavitan and its variants like Lavitan Cabelos e Barba), and Dermocosmetics (Bepantriz). The company distributes to over 60,000 points of sale, reaching 90% of Brazilian pharmacies, and leads in OTC medications, vitamins, and antigripal segments. Cimed also offers hangover relief products under the Ressaliv brand.

Differentiator

Problem solved

Functional benefit

Brands

• Carmed: Lip moisturizer brand that has achieved viral success; partnered with Fini, Larissa Manoela, Maisa, Barbie, Burger King, and Madonna; recorded R$400 million in revenue in the past year (2000% growth vs 2022).
• Lavitan
• K-Med
• Dermafeme
• Acnezil
• Ressaliv
• Cimegripe
• Nevralgex
• Bepantriz
• Xô Inseto!
• João e Maria
• Ciflogex
• Fexx
• Genéricos
• Puzzy

Products and services

• Carmed Lip balm brand and category leader in Brazil; viral collaborations with Fini, Larissa Manoela, Maisa, Barbie, Burger King, and Madonna; recorded R$400 million in revenue in 2023, representing 2000% growth versus 2022. Targeted at Brazilian consumers seeking flavored lip care.
• Lavitan Vitamin and supplement complex; the main product in Cimed's sports-related portfolio. Includes specialized variants such as Lavitan Cabelos e Barba (hair and beard) developed in partnership with Barbearia Corleone. Featured in the 2022 World Cup campaign with footballer wives. Distributed through pharmacy retail and the Lavitan 5G direct-to-consumer e-commerce storefront.
• K-MED Intimate lubricant brand and category leader with approximately 60% market share; positioned to destigmatize lubricant use and promote women's sexual wellness. Includes K MED Ice variants and is sold through Brazilian pharmacies.
• Dermafeme Intimate soap brand with rebranded packaging featuring celebrity ambassadors; associated with campaigns on feminine intimate health and menstrual poverty awareness via #EuSouMinhasEscolhas in partnership with Plan International Brasil and Grupo Dadivar.
• Acnezil Complete line of acne treatment products including gel (Acnezil Gel Secativo), liquid facial soap, and bar soap with active ingredients salicylic acid, niacinamide, and tea tree leaf extract. Targeted at consumers managing acne-prone skin.
• Ressaliv Hangover relief line including Ressaliv Pré (liver support supplement), carbonated isotonic beverages (Citrus and Tangerina flavors), and Ressaliv Dor (analgesic). Brazilian isotonic market moves approximately R$350 million annually with 15% category growth. Targeted at adult consumers seeking hangover and recovery solutions.
• Cimegripe Cold and flu medication brand, part of Cimed's OTC medicines portfolio. Targeted at Brazilian consumers treating cold and flu symptoms, with seasonal peaks driving significant revenue (R$1 billion expected for winter seasonal illness treatments in 2025).
• Nevralgex Pain relief medication for neuralgia and related conditions, distributed through Brazilian pharmacies as part of Cimed's OTC portfolio.
• Bepantriz Dermocosmetic product for skin care, part of Cimed's dermocosmetics category. Targeted at consumers seeking dermo-cosmetic skincare solutions.
• João e Maria Baby care product line, announced as a new brand in March 2024 alongside João Branco's board appointment. Targeted at parents of infants and young children.
• Xô Inseto! Insect repellent brand in Cimed's personal care portfolio, distributed through Brazilian pharmacies for everyday protection against mosquitoes and other insects.
• Puzzy by Anitta Intimate perfume launched in partnership with artist Anitta, expanding the personal care product line into Brazil's R$30 billion perfume market. Targeted at consumers seeking personal fragrances distributed through pharmacies.
• Genéricos Cimed Generic medications with accessibility-focused packaging featuring larger print for dosage information (redesigned in 2024). Cimed is a major player in Brazil's generic drugs market with 600+ products in its catalog and 50 new launches in 2022. Targeted at consumers seeking affordable prescription generics and OTC medications, with volume promotions such as 'pague um leve dois' campaigns.
• Ciflogex Medication brand in Cimed's OTC portfolio, distributed through Brazilian pharmacies. Targeted at consumers seeking accessible pharmaceutical treatments.
• Fexx Medication brand in Cimed's OTC portfolio, distributed through Brazilian pharmacies for the treatment of common conditions.

Quantifiable outcome

• 90% of Brazilian pharmacies reached
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

14 partnerships are on record, tiered core, minor and flagship.

• Pague Menos FarmáciacoreChannel Partner/ Reseller/ Distributor · 13 June 2024Strategic partnership for Ressaliv product launch, with Pague Menos as the first pharmacy chain present in all states and Federal District. Joint event in Fortaleza with artist Nattan, simultaneous national rollout across all regions.
• Viação CometacoreGTM or Marketing Partner · 1 June 2024Partnership for immersive bus tour activation 'Carmed com Cometa na Estrada' visiting 15 cities in São Paulo state. Joint experiential marketing with interactive bus featuring brand museum, customization workshops, and photo areas.
• Mattel (Barbie)coreGTM or Marketing Partner · 1 March 2024Licensed collaboration for Carmed Barbie collection celebrating Barbie's 65th anniversary. Three exclusive flavors: Pink, Rose Gold, and Crystal. Projected revenue of R$80 million in first days.
• FinicoreGTM or Marketing PartnerCollaboration that established Carmed as one of the most remembered lip balm brands. First major brand collaboration that drove viral success.
• Burger KingminorGTM or Marketing PartnerBrand collaboration for Carmed product that maintained brand visibility on TikTok and Instagram trends.
• AnittacoreGTM or Marketing PartnerPartnership with Brazilian pop star Anitta for Puzzy intimate perfume product launch, leveraging her celebrity status to promote the product in the R$30 billion Brazilian perfume market.
• Larissa ManoelaminorGTM or Marketing PartnerCarmed BFF collaboration featuring actress and singer as brand ambassador for lip balm products.
• CBF (Confederação Brasileira de Futebol)flagshipGTM or Marketing PartnerOfficial sponsor of all Brazilian national football teams since 2015, including men's and women's selections. Major brand visibility through World Cup cycles, home games, and football events. Extended sponsorship through 2026 cycle.
• Cruzeiro (Football Club)coreGTM or Marketing PartnerFive-star partnership until end of 2026 including main uniform logo for women's team, goalkeeper and coaching staff kits for men's team, captain bands, LED boards, training equipment, and brand presence at stadium.
• Palmeiras (Football Club)coreGTM or Marketing PartnerFootball club sponsorship with product supply and marketing activations.
• Mahmoud BaydounminorGTM or Marketing PartnerSexologist and influencer as brand ambassador for K-Med lubricant products, aiming to destigmatize lubricant use and promote women's sexual wellness.
• Share Your SexminorGTM or Marketing PartnerLargest Brazil-exclusive online community for women discussing sexuality (180,000+ members) partnering with K-Med for educational content and product awareness.
• Plan International BrasilminorOthersSocial responsibility partnership addressing menstrual poverty and female intimate health through campaign #EuSouMinhasEscolhas with Dermafeme brand.
• Grupo DadivarminorOthersSocial initiatives group structuring relationships between organizations, brands, and stakeholders through social causes, partnering for menstrual poverty campaign.

Scale indicators15 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• EMS: Brazil's largest pharmaceutical company by sales volume, competing head-to-head with Cimed in generics, OTC, and branded prescription medications across the same 60,000+ Brazilian pharmacy distribution footprint.
• Eurofarma: Major Brazilian pharmaceutical manufacturer with comparable generics, OTC, prescription, and personal care portfolios; directly competes with Cimed in the national pharmacy channel and adjacent consumer health segments.
• Hypera Pharma: Largest publicly traded Brazilian pharmaceutical company with leading OTC and consumer health brands; competes with Cimed in vitamins, OTC, and personal care categories through similar mass-market Brazilian pharmacy distribution.
• Aché Laboratórios: Privately held Brazilian pharmaceutical company with comparable portfolio breadth across prescription, OTC, generics, and dermocosmetics; competes with Cimed in the national pharmacy retail channel.
• Prati-Donaduzzi: Brazilian generic and OTC manufacturer; one of the three labs (with Cimed and Cristália) preparing semaglutida entries, and a direct competitor in generics and OTC categories distributed via Brazilian pharmacies.
• Cristália: Brazilian pharmaceutical company co-developing semaglutida with Biocon; competes with Cimed in prescription generics, hospital products, and selected OTC categories across Brazil.
• Biolab Farmacêutica: Brazilian pharmaceutical company with a comparable portfolio in prescription, OTC, dermocosmetics, and consumer health; distributes through the same national pharmacy retail network that Cimed serves.

Broad incumbents

• Sanofi (Brazil): Global pharmaceutical major with significant Brazil operations across vaccines, OTC, and prescription; competes broadly with Cimed in OTC categories while operating at much larger scale and brand reach.
• Bayer (Brazil): Multinational pharmaceutical and consumer health company with established Brazil presence; competes with Cimed in OTC, vitamins, and personal care through brands like Aspirin, Bepantol, and Elevit distributed in Brazilian pharmacies.
• GSK Consumer Healthcare (Brazil): Global consumer healthcare leader with Brazil operations in OTC (cold/flu, pain relief) and oral care; competes with Cimed in Cimegripe-adjacent cold/flu and broader OTC categories via the same pharmacy channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/canalgrupocimed
• Facebookfacebook.com/GrupoCimed
• LinkedInlinkedin.com/company/grupocimed
• Instagraminstagram.com/cimedremedios
• TikToktiktok.com/@cimed?lang=pt-BR

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Grupo Cimed